Bristol-Myers Squibb Signs New Agreement To Expand Access To Reyataz(R) (Atazanavir Sulfate) In Sub-Saharan Africa And India
Links shared publicly online about this topic.
- 183total visits
Bristol-Myers Squibb Signs New Agreement To Expand Access To Reyataz(R) (Atazanavir Sulfate) In Sub-Saharan Africa And India
Bristol-Myers Squibb Company (NYSE: BMY) today announced a new agreement to expand access to Reyataz® (atazanavir sulfate). The immunity-from-suit agreement signed with Matrix Laboratories Lim
View full resource at medicalnewstoday.com
Tags: HIV Medication, Reyataz, Bristol-Myers Squibb
Most Recently Shared on June 29, 2011 at 2:05 pm By:
Bristol-Myers Squibb Signs New Agreement To Expand Access To Reyataz(R) (Atazanavir Sulfate) In Sub-Saharan Africa And... http://mnt.to/3XNk
Also Shared By:
Advertisement
MNT HIV/Aids
@mnt_hivaids
Bristol-Myers Squibb Signs New Agreement To Expand Access To Reyataz(R) (Atazanavir Sulfate) In Sub-Saharan Africa And... http://mnt.to/3XNk
1 year ago...